BETA CAT PHARMACEUTICALS, LLC
BETA CAT PHARMACEUTICALS, LLC Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20130143920 | Methods for treatment of diseases and disorders related to transducin beta-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia. - Methods for treatment of diseases and disorders related to transducin β-like protein 1 (TBL1) activity, including myeloproliferative neoplasia, chronic myeloid leukemia, and acute myeloid leukemia. | 06-06-2013 |
20130123281 | Compositions and Methods for Inhibition of TBL-1 Binding to Disease-Associated Molecules - Compositions and methods which modulate diseases and disorders related to transducin β-like protein 1 (TBL1) activity, including but not limited to cancer, inflammation, and bone related diseases. | 05-16-2013 |